Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
3.950
+0.050 (1.28%)
At close: Jun 8, 2026, 4:00 PM EDT
3.820
-0.130 (-3.29%)
After-hours: Jun 8, 2026, 5:10 PM EDT
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $236.53 million as of June 8, 2026. Its market cap has increased by 125.32% in one year.
Market Cap
236.53M
Enterprise Value
157.98M
1-Year Change
125.32%
Ranking
Category
Stock Price
$3.95
Market Cap Chart
Since August 4, 2020, Orchestra BioMed Holdings's market cap has increased from $197.44M to $236.53M, an increase of 19.80%. That is a compound annual growth rate of 3.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 233.53M | -0.34% |
| Dec 31, 2025 | 234.33M | 54.11% |
| Dec 31, 2024 | 152.05M | -53.41% |
| Dec 29, 2023 | 326.34M | 191.65% |
| Dec 30, 2022 | 111.90M | -45.72% |
| Dec 31, 2021 | 206.14M | -21.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elicio Therapeutics | 243.93M |
| Anavex Life Sciences | 238.17M |
| SAB Biotherapeutics | 237.53M |
| Protara Therapeutics | 233.81M |
| Codexis | 232.70M |
| Minerva Neurosciences | 231.08M |
| Fate Therapeutics | 230.79M |
| Entrada Therapeutics | 229.53M |